Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Stoke Therapeutics Inc buy Cantor Fitzgerald

Start price
€12.40
10.12.24 / 50%
Target price
-
10.12.25
Performance (%)
132.26%
End price
€28.80
11.12.25
Summary
This prediction ended on 11.12.25 with a price of €28.80. The BUY prediction by Cantor_Fitzgerald for Stoke Therapeutics Inc saw massive gains of 132.26%. Cantor_Fitzgerald has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Stoke Therapeutics Inc 9.774% 9.774% 135.484%
iShares Core DAX® 0.734% -0.964% 17.910%
iShares Nasdaq 100 -2.686% -2.409% 4.267%
iShares Nikkei 225® -2.261% -4.038% 10.420%
iShares S&P 500 -1.346% -1.510% 1.615%

Comments by Cantor_Fitzgerald for this prediction

In the thread Stoke Therapeutics Inc diskutieren

Stoke Therapeutics, Inc. (NASDAQ: STOK) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
Ratings data for STOK provided by MarketBeat

In the thread Trading Stoke Therapeutics Inc
Prediction Buy
Perf. (%) 132.26%
Target price
Change
Ends at 10.12.25

Die von Cantor_Fitzgerald gewählte maximale Laufzeit wurde überschritten

Stopped prediction by Cantor_Fitzgerald for Stoke Therapeutics Inc

buy
Stoke Therapeutics Inc

Start price
Target price
Perf. (%)
€11.30
04.04.24
-
04.04.25
-50.00%
05.04.25